South & Central America Organ Preservation Solution Market Revenue to cross US$ 31,423.90 thousand by 2031

At 8.4% CAGR, South & Central America Organ Preservation Solution Market is Projected to be worth US$ 31,423.90 thousand by 2031, says The Insight Partners

According to The Insight Partners' research, the South & Central America organ preservation solution market was valued at US$ 16,602.01 thousand in 2023 and is expected to reach US$ 31,423.90 thousand by 2031, registering a CAGR of 8.4% from 2023 to 2031. Shift toward machine perfusion technique and strategic initiatives by market players are among the critical factors attributed to drive the South & Central America organ preservation solution market growth.

The machine perfusion technique involves continuously providing artificial perfusion to the blood vessels of a grafted organ. This helps actively control the temperature, partial oxygen pressure, chemical composition, and mechanical stress of the internal environment of the organ. Machine perfusion is an advanced technology involving organ perfusion with a controlled perfusion flow. This method helps maintain the organ's microvasculature, provide oxygen and nutrients to support tissue metabolism, and remove toxic metabolic waste. Ex-vivo machine perfusion devices have been studied for their function in various temperature conditions, e.g., normothermic machine perfusion (NMP) at 35-38